Yasemin Erdem

Yasemin Erdem

Auto-generated profile, based on publicly available information

Yasemin Erdem

Department of Dermatology and Venereology, Istanbul Faculty of Medicine Istanbul University Istanbul Turkey

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 June 2020 in Contact Dermatitis
Verified
Journal Article
Open access
PDF file
YEYasemin Erdem
Yasemin Erdem
IAIlknur Kivanc Altunay
Ilknur Kivanc Altunay
AÇAslı Aksu Çerman
Aslı Aksu Çerman
SISena Inal
Sena Inal
EUEce Ugurer
Ece Ugurer
EÖEsen Özkaya
Esen Özkaya
Click on the article title to read more.

1 November 2020 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
EÖEzgi Özkur
Ezgi Özkur
YEYasemin Erdem
Yasemin Erdem
IAİlKnur Kıvanç Altunay
İlKnur Kıvanç Altunay
DDDamla Demir
Damla Demir
NDNurcihan Çalışkan Dolu
Nurcihan Çalışkan Dolu
AÇAslı Aksu Çerman
Aslı Aksu Çerman
Hidradenitis suppurativa is a chronic inflammatory skin disease of terminal follicular acroinfundibulum. This study aimed to evaluate serum irisin, plasma glucose, insulin, and lipid levels in hidradenitis suppurativa, and elucidate possible associations with disease activity, inflammatory, or metabolic parameters. This case-control study included 37 patients (M/F: 9/28) and 37 sex-, age- and body mass index -matched healthy controls (M/F: 11/26). Demographic data, Hurley stage of disease, fasting glucose, insulin, total cholesterol, high density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, C-reactive protein levels, erythrocyte sedimentation rate, hematologic parameters, and serum irisin were assessed. The hidradenitis suppurativa group had significantly higher waist circumference than controls (p<0.001). Insulin resistance, defined as a homeostatic model assessment for insulin resistance value greater than 2.5, was observed in 45.9% of patients and 8.1% of controls (p=0.003), whereas metabolic syndrome was observed in 32.4% of patients and 5.4% of controls (p<0.001). Furthermore, plasma triglycerids, glucose, and insulin levels were significantly higher in the hidradenitis suppurativa (p=0.013, p=0.001, and p=0.004), respectively. Mean irisin level was insignificantly higher in the hidradenitis suppurativa group (37.4±32.6) than in controls (26.2±24.7, p=0.217). Physical activity and the exercise levels of participants were not documented. This study indicates that hidradenitis suppurativa patients have higher serum irisin, fasting plasma glucose, insulin, and triglycerides levels than healthy controls. Thus, the authors suggest that hidradenitis suppurativa patients should be evaluated for insulin resistance and metabolic syndrome, and monitored accordingly.

10 December 2020 in Dermatologic Therapy
Verified
Journal Article
Open access
PDF file
YEYasemin Erdem
Yasemin Erdem
AEAlgün Polat Ekinci
Algün Polat Ekinci
IAIlknur Kivanc Altunay
Ilknur Kivanc Altunay
OSOnur Sivaz
Onur Sivaz
SISena Inal
Sena Inal
EÖEsen Özkaya
Esen Özkaya
Background The Coronavirus Disease 2019 (COVID‐19) outbreak significantly affected the clinical practice in hospitals and the management of many diseases. Objective The aim of this study was to evaluate the effect of pandemic‐related factors on the severity and course of chronic urticaria (CU). Methods A total of 194 CU patients who were on regular follow‐up, were enrolled in the study. The disease activity was assessed by means of the weekly urticaria activity score (UAS7) and urticaria control test (UCT). Patients were divided into two subgroups according to their disease aggravation as “aggravated” and “non‐aggravated”. Two groups were compared in terms of demographic, clinical, COVID‐19‐associated parameters, and parameters related with the effect of COVID‐19 pandemic on CU management. Results The omalizumab use was statistically higher (P = .017), and the systemic corticosteroid use was statistically lower (P = .025) in the “aggravated” group. Adherence to quarantine was significantly lower in the ‘aggravated’ group (P = .027). 173 patients (89.2%) were unable to contact a dermatologist during the pandemic. Among 186 patients who received treatment for CU before the pandemic, 48 (25.8%) did not continue the existing treatment during the pandemic. CU aggravated in one patient with COVID‐19 and remained stable in the other. Conclusion The present study showed that CU patients, especially those on omalizumab therapy, had difficulties in attending medical care and even in the maintenance of their existing therapies during the pandemic. Creating novel follow‐up and treatment models as well as the increased use of teledermatology might be beneficial in the management of this life‐disturbing condition.

1 April 2021 in Contact Dermatitis
Verified
Journal Article
Open access
PDF file
YEYasemin Erdem
Yasemin Erdem
SISena Inal
Sena Inal
OSOnur Sivaz
Onur Sivaz
SCSevkiye Copur
Sevkiye Copur
KBKubra N. Boluk
Kubra N. Boluk
EÖEsen Özkaya
Esen Özkaya
Background: Hand eczema (HE) has increased among healthcare workers (HCWs) working in coronavirus disease‐2019 (COVID‐19) units, and was associated with increased hand hygiene practices.Objectives: To compare the prevalence and clinical characteristics of HE, and hand hygiene practices in HCWs working in COVID‐19 and non‐COVID‐19 units.Methods: A total of 244 HCWs working in COVID‐19 (n = 118) and non‐COVID‐19 patient care units (n = 126) were examined by dermatologists with regard to demographic parameters and hand hygiene practices. The COVID‐19 and non‐COVID‐19 groups were matched at a 1:1 ratio according to age, atopy, and generalized dry skin.Results: HE was more frequent in the COVID‐19 group (48.3% vs 12.7%, P < .001), whereas working years (P < .05) and additional housework at home (P < .001) were longer in the non‐COVID‐19 group. After the development of HE, moisturizing creams were reported to be more frequently used in the COVID group (P < .001). Topical corticosteroids were used in a minority (40% in the COVID group and 26.7% in the non‐COVID group).Conclusions: HCWs in COVID‐19 units developed HE more frequently. A majority increased the frequency of moisturizer use, instead of using topical corticosteroids, after the development of HE for the purpose of treating eczema. New approaches are needed for the prevention and management of HE in HCWs, especially by facilitating access to dermatologists.

1 November 2021 in Indian Journal of Dermatology
Verified
Journal Article
Open access
PDF file
YEYasemin Erdem
Yasemin Erdem
IAİlKnur Kıvanç Altunay
İlKnur Kıvanç Altunay
EÖEzgi Özkur
Ezgi Özkur
GŞGül Şekerlisoy
Gül Şekerlisoy
EKEzgi Aktaş Karabay
Ezgi Aktaş Karabay
AÇAslı Aksu Çerman
Aslı Aksu Çerman
Background: Melatonin is a hormone that regulates the sleep–wake cycle and has immunomodulatory and anti-inflammatory roles. Aims: The aim of this study is to assess melatonin levels and investigate the association with pruritus severity, sleep quality, and depressive symptoms in dermatoses with nocturnal pruritus. Methods: The study was a prospective study with 82 participants, including 41 patients and 41 healthy volunteers. The visual analog scale (VAS), Pittsburg Sleep Quality Index (PSQI), and Beck Depression Inventory (BDI) were recorded for each patient. To assess the melatonin levels, urinary 6-sulfatoxymelatonin levels in the first urine in the morning were measured. Results: Melatonin concentrations were significantly lower (P = 0.007), while the BDI (P = 0.001) and PSQI (P = 0.001) scores were significantly higher in the patients with pruritus than in the healthy control subjects. There was an inverse correlation between melatonin levels and PSQI scores (r = −0.355, P = 0.023), and a positive correlation was detected between BDI scores and PSQI scores (r = 0.631, P = 0.001) in the pruritus group. Conclusion: Melatonin levels were found to decrease in relation to sleep quality in nocturnal pruritus patients. Low melatonin levels in these patients may be associated with sleep disorders and pruritus.

1 January 2018 in SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital
Verified
Journal Article
Open access
YEYasemin Erdem
Yasemin Erdem
The Medical Bulletin of Sisli Etfal Hospital